SLC31A1 and bladder transitional cell carcinoma: In contrast, SLC31A1 expression is significantly upregulated in certain tumours such as those of bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cervical squamous cell carcinoma, endocervical adenocarcinoma (CESC), oesophageal carcinoma (ESCA), glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), and uterine corpus endometrial carcinoma (UCEC).